Hap Trading, LLC Kempharm, Inc Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$4.02 - $5.21 $46,229 - $59,915	-11,500 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$5.0 - $9.26 $28,500 - $52,782	-5,700 Reduced 33.14%	11,500 $2,000
Q4 2021 Feb 14, 2022	SELL	$7.6 - $10.26 $31,920 - $43,092	-4,200 Reduced 19.63%	17,200 $31,000
Q3 2021 Nov 10, 2021	SELL	$8.72 - $13.31 $252,880 - $385,990	-29,000 Reduced 57.54%	21,400 $21,000
Q2 2021 Aug 11, 2021	SELL	$8.52 - $15.47 $509,496 - $925,106	-59,800 Reduced 54.26%	50,400 $207,000
Q1 2021 May 14, 2021	BUY	$5.6 - $13.47 $617,120 - $1.48 Million	110,200 New	110,200 $295,000

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.